Targeting targeted therapy

N Engl J Med. 2004 May 20;350(21):2191-3. doi: 10.1056/NEJMe048101. Epub 2004 Apr 29.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics*
  • Adenocarcinoma, Bronchiolo-Alveolar / drug therapy
  • Adenocarcinoma, Bronchiolo-Alveolar / genetics
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Gefitinib
  • Genes, erbB-1*
  • Heterozygote
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics*
  • Mutation*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Quinazolines / therapeutic use*
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Quinazolines
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Gefitinib